Sign in to unlock AI Chat and more features

Clinical utility of serum chromogranin A as a marker of hepatocellular carcinoma in chronic hepatitis patients

Abstract

Background
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the third most common cause of cancer deaths accounting for about 745 000 deaths per year globally. HCC is often diagnosed at an advanced stage where effective therapies are lacking.
Aim
Is to investigate the role of serum chromogranin A (CgA) as a marker for detection of HCC in pa...
Keywords
Hepatocellular carcinoma
Medicine
Internal medicine
Gastroenterology
Cirrhosis
Hepatitis B virus
Hepatitis B
Liver function
Liver cancer
Chromogranin A
Cancer
Liver function tests
Viral hepatitis
Immunology
Virus
Immunohistochemistry
Sustainable Development Goals (SDG)
Good health and well-being



Clinical utility of serum chromogranin A as a marker of hepatocellular carcinoma in chronic hepatitis patients

Clinical utility of serum chromogranin A as a marker of hepatocellular carcinoma in chronic hepatitis patients

Abstract

Background
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the third most common cause of cancer deaths accounting for about 745 000 deaths per year globally. HCC is often diagnosed at an advanced stage where effective therapies are lacking.
Aim
Is to investigate the role of serum chromogranin A (CgA) as a marker for detection of HCC in pa...
Keywords
Hepatocellular carcinoma
Medicine
Internal medicine
Gastroenterology
Cirrhosis
Hepatitis B virus
Hepatitis B
Liver function
Liver cancer
Chromogranin A
Cancer
Liver function tests
Viral hepatitis
Immunology
Virus
Immunohistochemistry
Sustainable Development Goals (SDG)
Good health and well-being